Become a subscriber
Newsroom
Save the date - Arjo Capital Market Day 2019
Arjo invites financial analysts, institutional investors and media to the company’s first Capital Market Day in Malmö on March 12, 2019.
Arjo interim report January-September 2018
“After five years of declining growth, we have turned the business around and we now deliver growth for the third consecutive quarter. With a consistently strong order intake for the quarter and a continued positive outlook for the remainder of the year, we are now raising our forecast and expect organic net sales growth to be in the middle of the...
Arjo to divest low-spec medical beds business
Arjo, a market-leading supplier of medical devices and solutions, today signed an agreement to divest Acare – the group’s low-spec medical beds business – to China-based CBL Group. The divestment is a key part of the group’s action plan to improve profitability in the medical beds product category.
Arjo announces date of 2018 Q3 report and conference call
Arjo will issue its Q3 report for 2018 on Monday October 22nd at 13:15 CET, followed by a conference call at 14:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO.
Arjo interim report January-June 2018
“We continue to perform strongly as a standalone company and are now reporting positive growth for the second consecutive quarter. Net sales increased organically by 2.3% and we also reported improved EBITDA during the quarter. We enter the second half of the year with good confidence and will continue to build a profitable and sustainable Arjo.”,...
Arjo acquires ReNu Medical – a green medical reprocessor of single use medical devices
Arjo, a market-leading supplier of medical devices and solutions, today signed an agreement to acquire ReNu Medical Inc. ReNu Medical is a privately owned US company specialising in green reprocessing for single use non-invasive medical devices. The acquisition is expected to have a marginal positive effect on netsales, gross margin and earnings...
Arjo announces date of 2018 Q2 report and conference call
Arjo will issue its Q2 report for 2018 on Thursday July 19th at 08:00 CET, followed by a conference call at 09:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO.
Arjo enters into exclusive R&D partnership with Next Step Dynamics
Arjo, a market-leading supplier of medical devices and solutions, has entered into an exclusive partnership with Next Step Dynamics, a Swedish technology company specialising in predictive analytics, for development and sales of solutions for preventive healthcare. According to the terms of the partnership, Arjo has committed to spend
Arjo unveils IndiGo™ breakthrough technology for medical bed transport
First-of-its-kind solution delivers intuitive user experience and is the result of customer-focused product development approach.
Resolutions at Arjo’s Annual General Meeting
At the Annual General Meeting of Arjo AB held on 4 May 2018, the following was resolved.
Arjo interim report January-March 2018
“The strong start to the year with an organic sales growth of 2.3% shows that our increased external focus and the initiatives implemented to date are generating results. We have now taken the first important steps as an independent company and it is gratifying that, for the first time in three years, we are reporting a positive organic sales...
Arjo announces date of 2018 Q1 report and conference call
Arjo will issue its Q1 report for 2018 on Friday May 4 at 08:00 CET, followed by a conference call at 09:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO.
Arjo publishes Annual Report 2017
Today Arjo publishes the Annual Report 2017 on www.arjo.com.
NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB
The shareholders of Arjo AB (publ) are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Friday 4 May 2018 at 11.00 a.m. CET, in Clarion Hotel & Congress Malmö Live, Dag Hammarskjölds torg 2, Malmö, Sweden.
Arjo establishes SEK 2.5 billion commercial paper programme
Arjo AB is establishing a commercial paper programme with a framework amount of SEK 2.5 billion and is conducting a first issue of almost SEK 1.5 billion. The purpose of the programme is to diversify the group’s sources of financing.
Arjo year-end report January-December 2017
”We have seen a positive development in several markets in the fourth quarter, and in addition we see yet another positive quarter for our US rental business. However, the development in the UK remained challenging with low NHS investments. When adjusted for the DVT situation in the US in the fourth quarter 2016, we see a positive net sales...
Arjo announces joint partnership with Sony Mobile on unique tracking solution improving healthcare efficiency
Arjo, a global medical device company, today announces a joint partnership on a unique tracking solution with Sony Mobile Communications. The cloud-based solution aims to improve efficiency and quality of care by reducing time spent on locating critical equipment in healthcare environments.
Arjo announces date of 2017 year-end report and conference call
Arjo will issue its year-end report for 2017 on Monday January 29 at 08:00 CET, followed by a conference call at 09:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO.